Tech Company Financing Transactions
ChemT Biotechnology Funding Round
On 6/22/2026, ChemT Biotechnology raised $4 million in Seed funding from Wavemaker Partners, Draper University and Seeds Capital.
Transaction Overview
Company Name
Announced On
6/22/2026
Transaction Type
Venture Equity
Amount
$4,000,000
Round
Seed
Investors
Proceeds Purpose
The company intends to use the funds to support the continued expansion of its AI and experimental infrastructure, advancement of its AI-designed molecular products toward GMP standards and regulatory readiness, scaling of commercial partnerships, and further development of CelMo.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1 North Buona Vista Link, Elementum 10-01
Singapore, 139691
Singapore
Singapore, 139691
Singapore
Phone
Undisclosed
Website
Email Address
Overview
We are building the AI layer for CMC (Chemistry, Manufacturing & Controls), one of pharma's most important yet underserved challenges. Our platform helps pharma better understand the cells behind biologics manufacturing and provides the means to modulate them with precision, enabling faster process development, smoother validation, and lower-cost biologics production.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jie Sun
Co-Founder
Nicholas Gascoigne
President
Ling Wu
Browse more venture capital transactions:
Prev: 6/22/2026: Upscale AI venture capital transaction
Next: 6/23/2026: CroíValve venture capital transaction
Share this article
Where The Data Comes From
We document every notable VC transaction. VC investment data records on this site are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs